Research leadership The Roxbury Institute recently appointed Karen Herbst as Head of Research, signaling a strategic emphasis on advancing lipedema science. This presents a sales opportunity to engage with the research leadership to offer partnerships, clinical trial support, education programs, or data services aligned with ALT and lipedema care.

Integrated care With a multidisciplinary model across lipedema, dermatology, plastic & reconstructive surgery, and aesthetic medicine, there is potential to cross-sell medical devices, imaging, practice management software, or patient engagement tools to support comprehensive treatment pathways.

Global patient base Serving local and international patients, The Roxbury Institute is likely to seek scalable marketing, translation/localization services, telehealth enhancements, and international compliance support to sustain growth across diverse markets.

Growth potential Annual revenue in the mid-range and a lean to mid-sized team indicate opportunity to introduce scalable solutions for clinic operations, revenue cycle management, and digital marketing automation (e.g., ads, CRM, patient communications) to drive efficiency and patient acquisition.

Tech stack expansion Current tech usage includes Google Ads, WordPress, Klaviyo, and Webflow, suggesting openness to marketing automation, analytics integration, patient outreach platforms, and data-driven insights to optimize campaigns and patient journeys.